Menu
Log in
Forgot password
Log in
Forgot password

ANCO - Education and Empowering the Northern California Cancer Community

September 2026

08/31/2026 2:40 PM | Anonymous

Corporate Member News

  • The FDA approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells. 

Read More

  • The FDA approved Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in first-Line HER2+ Advanced Gastroesophageal Adenocarcinoma.

Read More

  • The FDA approved BESREMi® (ropeginterferon alfa-2b-njft) for the treatment of adults with essential thrombocythemia (ET).

Read More


Reibursement Updates

  • In this month’s edition of E-Reimbursement, Bobbi Rubell breaks down essential Q4 HCPCS coding updates, key takeaways from the FY 2027 Inpatient Prospective Payment System (IPPS) final rule, and critical industry shifts. Stay ahead of regulatory changes, billing updates, and rising audit risks.
Read More

  

Apply to Become a Member


4225 Solano Ave, #764
Napa, CA 94558
Phone (415) 472-3960

Association of Northern California Oncologists © 2025 | Privacy Policy | Disclaimer

Powered by Wild Apricot Membership Software